Glenmark Pharmaceuticals launched an authorised generic of Pfizer's kidney cancer drug Inlyta (axitinib) in the US.
Company news · 16 Nov 2026 · Glenmark Pharmaceuticals (GLENMARK)
Inlyta's US sales were about US$538.4 million in the 12 months to September 2026, per IQVIA.
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.